Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Elisabetta Ricciarelli"'
Autor:
Giuliana Baccino, Buenaventura Coroleu Lletget, Alberto Romeu, Ana Monzó, Mónica Romeu, Fernando Abellán-García Sánchez, Isidoro Bruna Catalán, Azucena Zapata, Juan A. García-Velasco, Elisabetta Ricciarelli, Sylvia Fernández-Shaw, José Luis Gómez Palomares, Javier Sánchez Caro, Jorge Cuadros Fernández, Federico Pérez Milán, Sofía Gameiro, Emilio Lizarraga Bonelli, Guido Pennings, Ricardo Loret de Mola, Susan Golombok, Marco Antonio Pessanha Lourenço, Débora Cristina Soares Faria, Ludmila Araujo Cruz, Marisa Herrera, R. Sergio Pasqualini, Eleuterio R. Hernández de Miguel
El enorme avance en el conocimiento de las bases moleculares de los procesos fisiológicos y de las bases de la enfermedad que se produce en la segunda mitad del siglo pasado da lugar a la configuración del llamado modelo biomédico o molecular del
Autor:
José Luis Simón Gómez, Belen Acevedo, Marta Gutiérrez Sánchez, Jorge Cuadros, Elisabetta Ricciarelli, Eleuterio R. Hernandez
Publikováno v:
Fertility and Sterility. 82:343-347
Objective To determine whether LH supplementation improved pregnancy and implantation rates in GnRH antagonist donor cycles. Design Donors were randomly assigned to a protocol using GnRH antagonist (GnRH-a) alone or GnRH-a + recombinant LH. Analysis
Autor:
Eli Y. Adashi, Kelly E. Mayo, Richard M. Rohan, John C. Mordacq, Lechoslaw T. Putowski, Doo Seok Choi, Elisabetta Ricciarelli, Wendy J. Scherzer
Publikováno v:
Journal of the Society for Gynecologic Investigation. 4:144-151
TO assess the in vivo regulation of ovarian insulin-like growth factor binding protein-4 (IGFBP-4) mRNA expression by gonadotropins and estrogen. Whole ovarian RNA, obtained from two models of follicular development, was extracted and analyzed by Nor
Publikováno v:
Endocrinology. 132:2507-2512
Most but not all of the established insulin-like growth factor-binding proteins (IGFBPs) are expressed in the rat ovary. To continue the process of characterizing these ovarian IGFBPs, a solution hybridization/RNase protection assay was used to study
Publikováno v:
Fertility and Sterility. 59:8-34
Objective To assess possible interfacing between the somatotrophic and reproductive axes. Design Literature review. Main Outcome Measures Ovarian growth hormone reception and action. Results The available literature strongly supports a permissive rol
Autor:
Derek LeRoith, Arye Hurwitz, Elisabetta Ricciarelli, Haim Werner, Eli Y. Adashi, Charles T. Roberts, Eleuterio R. Hernandez, Luis Botero
Publikováno v:
Molecular Endocrinology. 5:1799-1805
The intraovarian insulin-like growth factor (IGF) system constitutes a triad composed of ligands, receptors, and binding proteins. Although conventional radioligand receptor assays have documented the presence of specific receptors for insulin and in
Autor:
Arye Hurwitz, Derek LeRoith, Carol E. Resnick, Elisabetta Ricciarelli, Eleuterio R. Hernandez, Ron G. Rosenfeld, Eli Y. Adashi, Charles T. Roberts
Publikováno v:
Human Reproduction. 6:1213-1219
A large body of information now supports the existence of a complete intraovarian insulin-like growth factor (IGF) system replete with ligands, receptors, and binding proteins. Although much remains to be learned, the emerging consensus would suggest
Autor:
Maria A. Manzanares, Eleuterio R. Hernandez, Elisabetta Ricciarelli, Jose Lui Gómez-Palomares
Publikováno v:
Fertility and sterility. 93(4)
Objective To determine whether inducing ovulation with a GnRH agonist in patients with polycystic ovaries (PCO) would permit oocyte retrieval without the burden or risk of cancellation, coasting, or ovarian hyperstimulation syndrome (OHSS), thus main
Publikováno v:
Fertility and sterility. 91
We retrospectively studied 429 IVF donor cycles in which ovulation was triggered with either hCG (175 cycles) or GnRH agonist (254 cycles). Of the donors in whom ovulation was triggered with hCG, 3.2% developed symptoms of moderate (2.2%) or severe (
Publikováno v:
Fertility and sterility. 86(6)
Objective To evaluate the implant capacity of embryos derived from oocytes matured with a bolus of GnRH agonist. Design Donors were randomly assigned to a protocol using either GnRH agonist or recombinant (r) hCG to trigger ovulation. Analysis of var